In a cohort of CPVT patients, the RyR2-A4860G mutation had been detected in a 6-year-old girl who presented idiopathic ventricular fibrillation, was treated with β-blockers, and had an implantable cardioverter [33]. The gene discussed is RYR2; the disease is catecholaminergic polymorphic ventricular tachycardia.